RaQualia Pharma Inc. (4579.T) JPX
760.00
-3(-0.39%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
760.00
-3(-0.39%)
Currency In JPY
| Market Cap | 23.93B |
| Enterprise Value | 23.59B |
| P/E Ratio | 65.43 |
| PEG Ratio | 1.52 |
| Price/Sales Ratio | 4.67 |
| Price/Book Ratio | 2.59 |
| Enterprise/Revenue | 4.59 |
| Enterprise/EBITDA | 19.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.07 |
| Operating Margin | 0.12 |
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
| Revenue | 3.98B |
| Revenue/Share | 169.27 |
| Gross Profit | 3.27B |
| EBITDA | 971.88M |
| Net Income | 273.12M |
| Diluted EPS | 11.36 |
| Total Cash | 3.24B |
| Total Cash/Share | 137.98 |
| Total Debt | 2.9B |
| Total Debt/Equity | 0.42 |
| Current Ratio | 4.46 |
| Book Value Per Share | 293.3 |
| 52-Week Change | 74.31 |
| 52-Week High | 1,465 |
| 52-Week Low | 418 |
| Moving Average 50 Days | 829.7 |
| Moving Average 200 Days | 792.13 |
| Average Volume | 264,264 |
| Shares Outstanding | 24.46M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |